Cancer incidence is increasing because of the polluted environment and an unhealthy life style. The increased incidence has also been noticed in brain tumours, among them the most malignant form, glioblastoma.
This cancer is very agressive (the average life expectancy of patients with glioblastoma is one year).
Because of resistance to conventional and also modern treatment approaches the research should be focused in searching for new molecular targets and biomarkers in order to improve diagnosis and prediction of treatment response and prognosis. During this project the focus will be held on glioma stem cells and their role.
Recent scientific research has shown that these cells are responsible for tumour growth and expansion and probably even recidives.
Results of these activities will contribute to new forms of important diagnostic (staging of disease, predicted response to treatment) and potential therapeutic tools. A new biobank with tumour samples for mutual use will be created as well as an international network of health institutions and research centres. One of the project's main goals is also to establish a long-term collaboration among project partners.
Homepage Url: http://www.glioma.eu
Project data begin: November 2011Project data end: April 2015Approved costs: 1.297.719,29Region / Statistical region: Trieste, Udine, Venezia, Obalno-Kraška, OsrednjeslovenskaTypology: Public call for standard projects no. 02/2009
List of beneficiaries
The list of beneficiaries, the names of providers and their projects, and the amount of public funding for projects is being made publicly available, each year in February, in line with Article 7 of Commission Regulation (EC) No 1828/2006 and the European Transparency Initiative (COCOF April 23, 2008).
List of beneficiaries of the CBC Programme Italy-Slovenia 2007-2013 (last update: February 2017